Pirfenidone attenuates bleomycin-induced changes in pulmonary functions in hamsters

Proceedings of the Society for Experimental Biology and Medicine

Volumn 216, Issue 3, 1997, Pages 392-397

  Schelegle, Edward S ^a   Mansoor, Jim K ^b   Giri, Shri ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN SULFATE; HYDROXYPROLINE; PIRFENIDONE; PYRIDONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG SCREENING; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG HOMOGENATE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; SYRIAN HAMSTER;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0030816833     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44187     Document Type: Article

References (21)

1. Lazo JS, Hoyt DG, Sebti SM, Pitt BR. Bleomycin: A pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol Ther 47:347-358, 1990.
2. Crooke ST, Bradner WT. Bleomycin: A review. J Med 7:333-428, 1976.
3. Mansoor JK, Hyde DM, Schelegle ES. Contribution of vagal afferents to breathing pattern in rats with lung fibrosis. Respir Physiol 108:45-61, 1997.
4. Myre M, Allard S, Bernard C, Martin R. Clinical, functional and pathological correspondence in early stage idiopathic pulmonary fibrosis: Evidence for small airway obstruction 1-2. Respiration 53:174-186, 1988.
5. Snider GL, Celli BR, Goldstein RH, O'Brien JJ, Lucey EC. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studies. Am Rev Respir Dis 117:289-297, 1978.
6. Thrall RS, Scalise PJ. Bleomycin. In: Phan SH, Thrall RS, Eds. Pulmonary Fibrosis. New York: Marcel Dekker, Vol 1: pp231-293, 1995.
7. Oberley LW, Buettner GR. The production of hydroxy radical by bleomycin and iron (II). FEBS Lett 97:47-49, 1979.
8. Sausville EA, Peisach J, Horwitz SB. Effect of chelating agents and metal ions in the degradation of DNA by bleomycin. Biochemistry 17:2740-2746, 1978.
9. Sausville EA, Stein RW, Peisach J, Horwitz SB. Properties and products of the degradation of DNA by bleomycin and iron (II). Biochemistry 17:2746-2754, 1978.
10. Sugiura Y, Kikuchi T. Formation of superoxide and hydroxy radicals in iron (II)-bleomycin oxygen system: Electron spin resonance detection by spin trapping. J Antibiot 31:1310-1312, 1978.
11. Sugiura Y, Suzuki T, Kuwahara J, Tanaka H. On the mechanism of hydrogen peroxide, superoxide and ultraviolet light induced DNA cleavages of inactive bleomycin iron (III) complex. Biochem Biophys Res Commun 105:1511-1518, 1982.
12. Iyer SN, Wild JS, Schiedt MJ, Hyde DM, Margolin SB, Giri SN. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters. J Lab Clin Med 125:779-785, 1995.
13. Giri SN. Pharmacologic perspectives in pulmonary fibrosis research. In: Hollinger MA, Ed. Focus on pulmonary pharmacology and toxicology. CRC, Boca Raton, Florida. Vol 2: pp19-55, 1990.
14. Likens SA, Mauderly JL. Effect of elastase or histamine on single-breath N2 washouts in the rat. J Appl Physiol 52:141-146, 1982.
15. Dubois AB, Botelho SY, Bedell GN, Marshall R, Comroe JH. A rapid plethysmographic method for measuring thoracic gas volume: A comparison with nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest 35:322-326, 1956.
16. Wossner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small portions of this amino acid. Arch Biochem Biophys 93:440-447, 1961.
17. Renzi G, Milic-Emili J, Grassino AE. The pattern of breathing in diffuse lung fibrosis. Bull Eur Physiopathol Respir 18:461-472, 1982.
18. Berend N, Feldsien D, Cederbaums D, Cherniack RD. Structure-function correlation of early stages of lung injury induced by intratracheal bleomycin in the rabbit. Am Rev Respir Dis 132:582-589, 1985.
19. Goldstein RH, Lucey EC, Franzblau C, Snider GL. Failure of mechanical properties to parallel changes in lung connective tissue composition in bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis 120:67-73, 1979.
20. Trenchard DW, Gardner D, Guz A. Role of pulmonary vagal afferent nerve fibres in the development of rapid shallow breathing in lung inflammation. Clin Sci 42:251-263, 1972.
21. Vizek M, Frydrychova F, Houstek S, Palecek F. Effect of vagal cooling on lung function residual capacity in rats with pneumonia. Bull Eur Physiopathol Respir 19:23-26, 1983.